Research and analysis

Shingles immunisation programme [Shingrix®]: evaluation reports

Evaluation of the Shingrix® herpes zoster (shingles) vaccination programme in England: academic year 2023 to 2024.

Applies to England

Documents

Shingrix® vaccine coverage by ICB and LA (England), 1 March 2023 to 31 May 2024 (vaccinated to 23 July 2024)

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Shingrix® vaccine coverage by ICB and LA (England), September 2023 to February 2024 (vaccinated to end-April 2024)

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The next quarterly update to these statistics is scheduled to be released on Thursday 24 April 2025.

For reports covering earlier years, when Zostavax® was in use, see Herpes zoster (shingles) immunisation programme 2023 to 2024: evaluation reports.

Updates to this page

Published 29 August 2024
Last updated 30 January 2025 show all updates
  1. Added quarterly report for Q3 of epidemiological year 2023/24.

  2. Added quarterly report and data file for Q2 of epidemiological year 2023/24.

  3. First published.

Sign up for emails or print this page